Medtech Talk

194 Folgen

1. Trod Medical Focused on Developing RF Ablative Tools to Perform Precise Surgery on Soft Tissue

   Vom: 10.3.2017
2. Amphora's Tom Ressemann Looks Back On A Start-Up Life, Answers The Question: What Makes a Good CEO

   Vom: 3.3.2017
3. FundRx Finding the Formula to Bring LPs, VCs, Individuals to Fund Promising Medtech Start-Ups

   Vom: 24.2.2017
4. SetPoint CEO Arnold Recalls Path to Medtech, Progress in Using Neuromod to Alleviate Inflammation

   Vom: 17.2.2017
5. FDA Building Effective Fast Track for US Medtechs While Other Countries Starting to Show Delays

   Vom: 14.2.2017
6. Optum’s Clark Says Medtechs Need to Craft Effective Message to Win Support from Payers and Providers

   Vom: 5.2.2017
7. A Little Bit Wall Street, A Little Bit Rock ’n’ Roll: Red Crow’s Co-founders Help Start-ups Find $$

   Vom: 27.1.2017
8. Lightstone’s Enxing Seng Brings Multiple Perspectives to Finding Solutions for Medtech Start-ups

   Vom: 20.1.2017
9. Metavention’s Kevin Hykes Explains How Past Success Can Guide Medtech's Future

   Vom: 13.1.2017
10. Can Robot-Assisted Surgery Carve a Niche in Ophthalmology?

    Vom: 6.10.2016
11. BrainScope Scores FDA approval for Concussion Dx Device, Moves into Commercialization

    Vom: 30.9.2016
12. Medtech M&A: McEvoy on Where Will AMO Fit into J&J & What the Deal Means for Eye Care

    Vom: 21.9.2016
13. From the Fundraising Front: How Rox Medical Made the Move to Hypertension and Raised $40m

    Vom: 16.9.2016
14. A MedtechTalk Mea Culpa

    Vom: 8.9.2016
15. Everything Medtech Companies Need to Know About Making Friends (& Closing Deals) in China

    Vom: 26.8.2016
16. Where Are Series A Dollars Coming From? What Areas Are Ripe for M&A? You May Be Surprised

    Vom: 19.8.2016
17. ReVision CEO John Kilcoyne Says the Company is Ready to Build a New Medtech Market in Ophthalmology

    Vom: 11.8.2016
18. What Will Carl Zeiss Meditec’s New Ophthalmology Unit Look Like? We Ask Jim Mazzo.

    Vom: 4.8.2016
19. From an "Ah, Ha!" Moment to Restoring Sight – Innovator Mark Humayun, MD, on What Drives Innovation

    Vom: 27.7.2016
20. Cartiva’s FDA Win for Approval of First Synthetic Cartilage Signals Change for Orthopedics

    Vom: 21.7.2016